NCT06204120

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

A Multicenter, Randomized, Double-blind, Placebo, Positive Drug Parallel Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Luye Pharma Group Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A randomized, double-blind, placebo/positive drug parallel controlled design was used to evaluate the preliminary efficacy and safety of intravenous infusion of LPM3480392 injection using different dosing regimens in subjects with moderate to severe pain after abdominal surgery.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	LPM3480392 Injection	PCA administration
DRUG	Placebo	PCA administration
DRUG	morphine hydrochloride injection	PCA administration

Timeline

• Start date: 2022-11-25
• Primary completion: 2023-07-04
• Completion: 2023-07-04
• First posted: 2024-01-12
• Last updated: 2024-01-12

Locations

1 site across 1 country: China